Related Experiment Video

Updated: Jan 25, 2026

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity
10:22

Basophil Activation Test for Investigation of IgE-Mediated Mechanisms in Drug Hypersensitivity

Published on: September 16, 2011

34.1K

Recent developments in drug hypersensitivity in children

Ilknur Kulhas Celik1, Emine Dibek Misirlioglu1, Can Naci Kocabas2

  • 1a Division of Pediatric Allergy and Immunology , University of Health Sciences, Ankara Child Health and Diseases Hematology Oncology Training and Research Hospital , Ankara , Turkey.

Expert Review of Clinical Immunology
|May 9, 2019
PubMed

Insights

Pediatric drug hypersensitivity reactions (DHRs) require accurate diagnosis. Standardized allergy testing is crucial for children, necessitating further research to develop precise diagnostic methods.

Area of Science:

  • Pediatric Allergy and Immunology
  • Clinical Pharmacology
  • Public Health

Background:

  • Drug allergy is a significant public health concern, contributing to 0.4-10.3% of pediatric hospital admissions.
  • Pediatric drug hypersensitivity reactions (DHRs) present unique epidemiological, clinical, and diagnostic challenges compared to adults.
  • Existing diagnostic and management algorithms for DHRs in adults are often inappropriately applied to children due to limited pediatric-specific evidence.

Purpose of the Study:

  • To review recent advancements in understanding pediatric DHRs.
  • To discuss the epidemiology, clinical manifestations, and diagnostic strategies for DHRs in children.
  • To highlight the need for evidence-based approaches in pediatric drug allergy management.

Main Methods:

  • Literature review focusing on recent developments in pediatric drug hypersensitivity.
  • Analysis of current understanding of DHR epidemiology and clinical presentations in children.
  • Evaluation of diagnostic approaches and the role of allergy testing in pediatric DHRs.

Main Results:

  • Misdiagnosis, under-diagnosis, and self-diagnosis of drug allergies are prevalent issues in pediatric populations.
  • Viral infections frequently complicate the diagnosis of DHRs in children.
  • Accurate identification of true DHRs is essential for effective management.

Conclusions:

  • A comprehensive allergy work-up, including standardized drug allergy tests, is vital for diagnosing DHRs in children.
  • Current diagnostic tests for DHRs in pediatric patients lack standardization.
  • Future research with larger pediatric cohorts is required to establish accurate, standardized diagnostic tests for DHRs in children.

Keywords:
Childrendrug allergydrug hypersensitivitymanagementrecent developments

More Related Videos

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization09:57

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization

Published on: September 20, 2024

3.5K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.3K

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
266
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
7.3K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
324
Sustainable Development01:43

Sustainable Development

As the human population continues to grow and use resources, we must be mindful of our planet’s natural limits. Sustainable development provides a pathway to maintain and improve human life now while also ensuring that future generations will have the resources that they need. The long-term success of sustainability efforts rests on understanding the interplay between human actions and ecological systems.
14.8K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
410
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
155